Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Ascendis Pharma A/S - Ordinary Share (NQ:ASND)

247.50 -7.96 (-3.12%)

Streaming Delayed Price Updated: 11:41 AM EDT, Aug 13, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	320,635
Open	250.38
Bid (Size)	247.01 (100)
Ask (Size)	248.00 (100)
Prev. Close	255.46
Today's Range	244.12 - 251.43
52wk Range	186.05 - 282.15
Shares Outstanding	57,152,295
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Ascendis Pharma A/S Q2 Earnings Call Highlights ↗

Today 10:05 EDT

Ascendis Pharma A/S (NASDAQ:ASND) reported second-quarter 2026 total revenue of EUR 339 million, including EUR 315 million in product revenue, as demand for its three commercial TransCon-based...

Via MarketBeat

Here's How Much $100 Invested In Ascendis Pharma 5 Years Ago Would Be Worth Today ↗

August 11, 2026

Ascendis Pharma (NASDAQ:ASND) has outperformed the market over the past 5 years by 5.62% on an annualized basis producing an average annual return of 17.21%. Currently, Ascendis Pharma has a market...

Via Benzinga

Performance

YTD	+16.0%	+16.0%
1 Month	-6.7%	-6.7%
3 Month	+1.6%	+1.6%
6 Month	+11.7%	+11.7%
1 Year	+26.3%	+26.3%

More News

Ascendis Pharma (NASDAQ:ASND) Combines High Growth Momentum with a Breakout Setup ↗

August 11, 2026

Via Chartmill

Ascendis Pharma (ASND) Shows High Growth Momentum With Bull Flag Breakout Setup ↗

July 20, 2026

Via Chartmill

ASCENDIS PHARMA A/S (NASDAQ:ASND) Screens as a High-Growth Momentum Candidate ↗

May 18, 2026

Via Chartmill

What to Know About This Fund’s $50 Million Exit From Ascendis Pharma ↗

May 14, 2026

Via The Motley Fool

Ascendis Pharma (NASDAQ:ASND) Shares Drop After Q4 Earnings Miss on Wider-Than-Expected Loss ↗

February 11, 2026

Via Chartmill

ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) Combines Minervini Trend Template with High Growth Momentum ↗

January 28, 2026

Via Chartmill

Energy Fund Yielding 7% and Up 14% in a Year Still Wasn’t Enough to Stop This $3 Million Exit ↗

May 09, 2026

Via The Motley Fool

Ascendis (ASND) Q1 2026 Earnings Call Transcript ↗

May 08, 2026

Via The Motley Fool

Ascendis Pharma Completes Strategic Trifecta with U.S. Launch of YUVIWEL and Seven-Year Orphan Exclusivity

April 13, 2026

Via MarketMinute

Earnings Scheduled For November 12, 2025 ↗

November 12, 2025

Via Benzinga

A Look Ahead: Ascendis Pharma's Earnings Forecast ↗

November 11, 2025

Via Benzinga

Agriculture Stock Up 53% Draws $12 Million Bet. Here's What Long-Term Investors Should Know ↗

March 20, 2026

Via The Motley Fool

Ascendis (ASND) Q4 2025 Earnings Call Transcript ↗

February 23, 2026

Via The Motley Fool

Praxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 Million ↗

February 22, 2026

Via The Motley Fool

Celcuity Stock Soars 700% in a Year as One Investor's $17 Million Buy Helps Create Top Two Position ↗

February 22, 2026

Via The Motley Fool

Apogee Shares Up Nearly 100% in 12 Months, and This $62 Million Buy Signals Ongoing Conviction ↗

February 22, 2026

Via The Motley Fool

$80 Million Arcellx Sale Follows Steep Stock Drop as Rival Drug Emerges ↗

February 22, 2026

Via The Motley Fool

Ascendis Pharma (ASND) Q4 2025 Earnings Transcript ↗

February 11, 2026

Via The Motley Fool

Ascendis Pharma (NASDAQ:ASND) Passes Minervini's Trend Template and High Growth Momentum Scan ↗

December 25, 2025

Via Chartmill

Why Dyne Therapeutics Stock Was Crushing it This Week ↗

November 21, 2025

Via The Motley Fool

European ADRs Navigate Choppy Waters: Pharma Sector Shows Resilience Amidst Broader Market Volatility

November 19, 2025

Via MarketMinute

Ascendis (ASND) Q3 2025 Earnings Call Transcript ↗

November 13, 2025

Via The Motley Fool

Ascendis Pharma Likely To Report Narrower Q3 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗

November 12, 2025

Via Benzinga

Frequently Asked Questions

Is Ascendis Pharma A/S - Ordinary Share publicly traded?

Yes, Ascendis Pharma A/S - Ordinary Share is publicly traded.

What exchange does Ascendis Pharma A/S - Ordinary Share trade on?

Ascendis Pharma A/S - Ordinary Share trades on the Nasdaq Stock Market

What is the ticker symbol for Ascendis Pharma A/S - Ordinary Share?

The ticker symbol for Ascendis Pharma A/S - Ordinary Share is ASND on the Nasdaq Stock Market

What is the current price of Ascendis Pharma A/S - Ordinary Share?

The current price of Ascendis Pharma A/S - Ordinary Share is 247.50

When was Ascendis Pharma A/S - Ordinary Share last traded?

The last trade of Ascendis Pharma A/S - Ordinary Share was at 08/13/26 11:41 AM ET

What is the market capitalization of Ascendis Pharma A/S - Ordinary Share?

The market capitalization of Ascendis Pharma A/S - Ordinary Share is 14.15B

How many shares of Ascendis Pharma A/S - Ordinary Share are outstanding?

Ascendis Pharma A/S - Ordinary Share has 14B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.